Suggestions
Yesenia Green
Sr Manager, Competitive Intelligence at Foundation Medicine
Professional Background
Yesenia Green is a highly accomplished professional in the field of molecular and cellular biology, with extensive experience in competitive intelligence, strategy, and business development within the life sciences sector. Currently serving as a Senior Manager of Competitive Intelligence at Foundation Medicine, Yesenia has played a crucial role in advancing the understanding of oncology through data-driven insights and strategic initiatives. Her strong analytical capabilities and keen understanding of market dynamics enable her to contribute significantly to the company's mission of providing comprehensive genomic profiling to personalize cancer treatment.
Prior to her role at Foundation Medicine, Yesenia held various positions at EMulate Therapeutics, Inc., formerly known as Nativis, Inc., where she transitioned from Business Development Specialist to Senior Analyst in Strategy & Business Development. Her contributions at EMulate Therapeutics were pivotal in developing strategic partnerships, enhancing product commercialization efforts, and following market trends to ensure the company remained at the forefront of advancements in technology and healthcare solutions.
Yesenia's experience extends to her time at Life Science Washington, where she served as the Associate Director of Capital Formation & Partnerships and as a Commercialization Manager. Throughout her tenure, she successfully facilitated connections between entrepreneurs and investors, cultivating a thriving ecosystem for life sciences innovation. Her role as Program Manager at WINGS, The Washington Medical Technology Angel Network, further reinforced her commitment to fostering early-stage companies through mentorship and funding opportunities.
Her rich background also includes a tenure as a Technology Licensing Fellow at the University of Washington Center for Commercialization, where she gained invaluable insights into intellectual property management and commercialization strategies while supporting innovative research initiatives. As a Graduate Research Assistant at the renowned Fred Hutchinson Cancer Research Center, Yesenia contributed to groundbreaking research efforts and honed her scientific expertise in a collaborative environment.
Education and Achievements
Yesenia Green's educational journey reflects her deep passion for science and her commitment to making impactful contributions to the field of biology. She earned her Doctor of Philosophy (Ph.D.) in Molecular and Cellular Biology from the University of Washington, where she developed a robust understanding of intricate biological processes and advanced her research skills. The rigorous training she received during her doctoral studies equipped her with the tools needed to excel in both academic and industry settings.
Prior to her Ph.D., Yesenia obtained her Bachelor of Science (BS) in Biochemistry and Biophysics from Oregon State University. This foundational knowledge set the stage for her future endeavors and provided her with a well-rounded understanding of the biochemical principles that govern life.
Achievements
Throughout her career, Yesenia has made significant strides in enhancing the intersection of science and business. Her expertise in competitive intelligence has enabled her to successfully gather market intelligence, analyze competitor activities, and identify emerging trends to guide strategic planning. This vital skill set is particularly beneficial for companies in the rapidly evolving biopharmaceutical landscape.
As a thought leader in her field, Yesenia has presented her research findings and business strategies at conferences and industry panels, sharing insights on the importance of strategic partnerships and innovation within the life sciences sector. Her commitment to education and mentorship has also inspired many up-and-coming professionals in the industry.
Yesenia Green’s interdisciplinary background, coupled with her leadership in various impactful roles, positions her as a key player in the ever-evolving landscape of molecular and cellular biology. Her work continues to inspire collaboration and innovation, making her a valuable asset to any organization focused on advancing health and technology.
